Skip to content

Screen for the high-risk factors of intrauterine adhesions after abortion and curettage

Research on New Technologies for Reproductive Health and Diagnosis & Treatment of Common Gynecological Diseases – Development and Application of Early Warning Systems and Novel Prevention/Therapeutic Techniques for Intrauterine Adhesions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107910
Enrollment
Unknown
Registered
2025-08-20
Start date
2023-04-11
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine adhesions

Interventions

Inevitable abortion patients:None

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 25–45 years. 2. Diagnosed with inevitable abortion at 6–12 weeks of gestation, with chromosomal testing required for the products of conception after uterine evacuation. 3. Voluntary participation in the study with signed informed consent. If the participant is unable to read the informed consent form (e.g., illiterate participants), an impartial witness must observe the consent process and co-sign the document.

Exclusion criteria

Exclusion criteria: 1. Patients who have not undergone ultrasound examination within 2 weeks after uterine evacuation. 2. Patients with autoimmune or infectious diseases, including hepatitis B, syphilis, systemic lupus erythematosus (SLE), etc. 3. Vulnerable populations (other than illiterate individuals and pregnant women), such as those with mental illness, cognitive impairment, critical illness, or minors.

Design outcomes

Primary

MeasureTime frame
Intrauterine adhesions;Endometrial thickness;

Countries

China

Contacts

Public ContactSongying Zhang

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

zhangsongying@126.com+86 571 8600 2222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026